Related Experiment Video
Updated: Feb 7, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Challenges of NK cell-based immunotherapy in the new era
Fang Fang1,2, Weihua Xiao3,4, Zhigang Tian5,6
1Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Signaling Network, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, 230027, China.
Abstract:
Natural killer cells (NKs) have a great potential for cancer immunotherapy because they can rapidly and directly kill transformed cells in the absence of antigen presensitization. Various cellular sources, including peripheral blood mononuclear cells (PBMCs), stem cells, and NK cell lines, have been used for producing NK cells. In particular, NK cells that expanded from allogeneic PBMCs exhibit better efficacy than those that did not. However, considering the safety, activities, and reliability of the cell products, researchers must develop an optimal protocol for producing NK cells from PBMCs in the manufacture setting and clinical therapeutic regimen. In this review, the challenges on NK cell-based therapeutic approaches and clinical outcomes are discussed.
Insights
Natural killer (NK) cells show promise for cancer immunotherapy by directly eliminating tumor cells. Optimizing NK cell production from peripheral blood mononuclear cells (PBMCs) is crucial for safe and effective clinical applications.
Area of Science:
- Immunology
- Cancer Research
- Cell Therapy
Background:
- Natural killer (NK) cells are potent immune cells capable of directly killing cancer cells without prior sensitization.
- NK cells can be sourced from various origins, including peripheral blood mononuclear cells (PBMCs), stem cells, and established cell lines.
- Allogeneic NK cells expanded from PBMCs demonstrate enhanced therapeutic efficacy compared to other sources.
Purpose of the Study:
- To review the challenges and clinical outcomes associated with NK cell-based cancer immunotherapy.
- To highlight the need for optimized protocols for manufacturing NK cells from PBMCs for therapeutic use.
Main Methods:
- Literature review of existing studies on NK cell expansion and therapeutic applications.
- Analysis of safety, activity, and reliability considerations for cell product manufacturing.
- Discussion of clinical outcomes and challenges in NK cell-based therapy.
Main Results:
- NK cells offer a promising avenue for cancer immunotherapy due to their direct cytotoxic activity.
- Expansion of allogeneic NK cells from PBMCs shows superior efficacy.
- Development of standardized manufacturing protocols is essential for clinical translation.
Conclusions:
- NK cell therapy holds significant potential for cancer treatment.
- Further research is required to establish optimal, safe, and reliable protocols for large-scale NK cell production from PBMCs.
- Addressing manufacturing challenges is key to advancing NK cell-based therapeutic regimens.
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Tumor Immunotherapy
Lewis Acids and Bases
A coordinate covalent bond (or dative bond) occurs when one of the atoms in the bond provides both bonding electrons. For example, a coordinate covalent bond occurs when a water molecule combines with a hydrogen ion to form a hydronium ion. A coordinate covalent bond also results when...
Base Excision Repair
The first step of...
Weak Base Solutions
Ions as Acids and Bases
Salts are ionic compounds composed of cations and anions, either of which may be capable of undergoing an acid or base ionization reaction with water. Aqueous salt solutions, therefore, may be acidic, basic, or neutral, depending on the relative acid-base strengths of the salt’s constituent ions. For example, dissolving the ammonium chloride in water results in its dissociation, as described by the equation:

